GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CCCC · Mar 31, 2026

C4 Therapeutics, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001628280-26-033865General Corporate
Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

1.04% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-486.74% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-15.00% · CORE · NOT_ENOUGH_HISTORY

Operating margin13thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

-451.64% · CORE · VALID

R&D intensity75thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

399.97% · OPTIONAL · VALID

SBC intensity13thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

43.42% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History4 statesHistory building
Period transition

What moved in the state?

Capex Intensity Decreased
Previous
1.69%
Current
1.04%
Delta
-0.65%
Cash Generation Decreased
Previous
-274.55%
Current
-486.74%
Delta
-212.18%
Growth Decreased
Previous
1.02%
Current
-15.00%
Delta
-16.02%
Profitability Decreased
Previous
-320.53%
Current
-451.64%
Delta
-131.11%
R And D Intensity Increased
Previous
289.98%
Current
399.97%
Delta
109.98%
Sbc Intensity Decreased
Previous
53.13%
Current
43.42%
Delta
-9.71%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.